ClinicalTrials.gg
RecruitingNCT07944950FOC-LABORUpdated Nov 18, 2026

Fear of Childbirth and Its Association With Mode of Delivery, Labor Pain, and Epidural Analgesia Request in First-Time Mothers

An observational study in Fear of Childbirth, LABOR PAİN and Ceserean Section, sponsored by Ankara City Hospital Bilkent. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Ankara City Hospital Bilkent · Observational

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
300
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-19

Among 120 studies in Labor Pain with a site in Turkey — 23 open to participants now, 31 under way, none of them phase 3. Labor Pain · Turkey.

Started
2026
with 15 others
Observational
8 of 120
3 open now
Primary completion
2026-12
later than 25 of 30 live
Registered
120th of 120
by date
Lead sponsor
4 of 120
Ankara City Hospital Bilkent

Among the 120 studies in Labor Pain with a site in Turkey, this one is one of 16 that started in 2026, is one of 8 observational ones, reaches primary completion later than 25 of the 30 other live ones, and was the 120th registered.

Labor Pain

426 studies on the registry are indexed under Labor Pain; 76 are open to participants now.

Browse Labor Pain studies →

Open to participants now

23 of the 120 studies in Labor Pain with a site in Turkey are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 31 Labor Pain studies recruiting now, 8 (26%) set no upper age limit and 23 (74%) stop at 75 or younger; 3 take children under 18; 20 take healthy volunteers.

This study: 18 Years to 45 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 120 studies in Labor Pain with a site in Turkey, or all of them as a file.
02

Study summary

The goal of this observational study is to learn whether the level of fear of childbirth before active labor is related to how the baby is born, how intense labor pain is, and whether epidural pain relief is requested, in first-time mothers with a full-term pregnancy who plan a vaginal birth.

The main questions it aims to answer are:

  • Do women with severe fear of childbirth have a higher rate of unplanned (emergency) cesarean delivery?
  • Do women with more fear of childbirth feel more intense labor pain?
  • Do women with more fear of childbirth ask for an epidural more often, and earlier in labor?

Researchers will compare women with severe fear of childbirth (a score of 85 or higher on the Wijma Delivery Expectancy/Experience Questionnaire, version A, or W-DEQ-A) with women whose scores are below 85.

Participants will:

  • Fill out the Turkish version of the W-DEQ-A, a 33-item questionnaire about thoughts and feelings regarding the coming birth. It is completed once after admission to the labor ward, before active labor and before any pain relief, and takes about 10 to 15 minutes.
  • Rate their labor pain on a scale from 0 (no pain) to 10 (worst imaginable pain) during active labor and, if they ask for an epidural, at the time of the request.
  • Receive routine labor care. The study does not change any treatment or clinical decision; information on labor, pain relief and delivery will be collected from hospital records.

The study will take place at Ankara Bilkent City Hospital in Ankara, Türkiye.

Read the detailed description

BACKGROUND

Fear of childbirth (FOC) is common in pregnancy. A systematic review and meta-analysis of 29 studies including 853,988 pregnant women estimated the worldwide pooled prevalence of tocophobia at 14% (95% confidence interval 12-16%). Previous studies have linked FOC to requests for cesarean delivery without a medical indication, longer labor, greater use of epidural analgesia and a more negative birth experience. Evidence on whether fear measured before active labor predicts intrapartum outcomes in nulliparous women who plan a vaginal birth is inconsistent, and prospective data from Türkiye, which has the highest cesarean delivery rate among OECD countries, are limited.

The Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ) is the most widely used instrument for measuring FOC. Version A (W-DEQ-A) assesses a woman's expectations of the coming birth during pregnancy. It consists of 33 items rated on a 6-point Likert scale (0-5), giving a total score from 0 to 165; higher scores indicate greater fear, and a score of 85 or higher is commonly used to define severe FOC. The Turkish version of the W-DEQ-A has been validated in pregnant women (Cronbach's alpha 0.89).

OBJECTIVES

Primary objective: to determine whether severe FOC (W-DEQ-A score of 85 or higher), measured before active labor, is associated with intrapartum (unplanned) cesarean delivery in nulliparous women with a term singleton pregnancy who plan a vaginal birth.

Secondary objectives: to assess the association of FOC, analyzed both as a continuous W-DEQ-A score and as a dichotomous group, with (1) mode of delivery, (2) labor pain intensity, and (3) the request for epidural labor analgesia and the cervical dilatation at which it is requested.

Exploratory objectives: to describe the duration of the active first stage and second stage of labor and the indications for intrapartum cesarean delivery according to FOC level.

DESIGN AND SETTING

This is a single-center, prospective observational cohort study conducted in the labor and delivery unit of the Department of Obstetrics and Gynecology, Ankara Bilkent City Hospital, a tertiary referral center in Ankara, Türkiye. The investigators do not assign any intervention. Labor management, induction, analgesia and decisions on operative delivery follow routine institutional practice and are made by the attending clinical team. W-DEQ-A scores will not be shared with the team managing labor, so that clinical decisions are not influenced by the study.

PARTICIPANTS AND PROCEDURES

Nulliparous women aged 18 to 45 years with a singleton, cephalic, term pregnancy (37+0 to 41+6 weeks) who are admitted for planned vaginal birth, either in the latent phase of spontaneous labor or for induction of labor, will be screened consecutively. After written informed consent, and before active labor (cervical dilatation less than 5 cm) and before any analgesia, participants will complete the Turkish W-DEQ-A in a quiet setting. Sociodemographic and obstetric characteristics will be recorded on a standardized data collection form that contains no names or national identity numbers. Labor, delivery and neonatal data will be collected prospectively by the research team and verified against medical records until discharge.

EXPOSURE

The exposure is the W-DEQ-A total score, analyzed as a continuous variable (per 10-point increase) and dichotomized at 85 (severe FOC versus non-severe FOC).

OUTCOME ASSESSMENT

  • Mode of delivery: spontaneous vaginal, operative vaginal (vacuum or forceps) or intrapartum cesarean delivery, with the primary indication for cesarean delivery.
  • Labor pain: 10-cm visual analogue scale (VAS; 0 = no pain, 10 = worst imaginable pain) at the first vaginal examination showing cervical dilatation of 5 cm or more before any analgesia, and at the time of an epidural request before the block is placed.
  • Epidural analgesia: whether the participant requests epidural analgesia, the time and cervical dilatation at the request, and whether the epidural is placed.
  • Labor characteristics: onset of labor (spontaneous or induced), oxytocin augmentation, duration of the active first stage and second stage of labor, birth weight and Apgar scores.

COVARIATES

Prespecified potential confounders are maternal age, body mass index, education level, gestational age, attendance at antenatal education classes, onset of labor (spontaneous or induced) and birth weight. Epidural analgesia and oxytocin augmentation lie on the possible causal pathway between FOC and mode of delivery; they will be examined as mediators in sensitivity analyses rather than adjusted for in the main model.

SAMPLE SIZE

Assuming an intrapartum cesarean rate of 25% among women with a W-DEQ-A score below 85 and a 20% prevalence of severe FOC (group ratio 1:4), 460 women (92 with severe FOC and 368 without) are needed to detect an increase in the cesarean rate to 40% (relative risk 1.6; odds ratio 2.0) with 80% power and a two-sided alpha of 0.05. To allow for about 10% incomplete data or protocol deviations, 512 women will be enrolled.

STATISTICAL ANALYSIS

Continuous variables will be summarized as mean (standard deviation) or median (interquartile range) and compared with the t-test or Mann-Whitney U test; categorical variables will be compared with the chi-square or Fisher's exact test. Multivariable logistic regression will estimate the association of FOC with intrapartum cesarean delivery and with epidural request, reported as adjusted odds ratios with 95% confidence intervals. Linear regression will be used for VAS scores and for cervical dilatation at epidural request. The ability of the W-DEQ-A score to discriminate women who undergo intrapartum cesarean delivery will be explored with receiver operating characteristic (ROC) analysis. A two-sided p value below 0.05 will be considered statistically significant.

ETHICS AND DATA PROTECTION

The study will start only after approval by the Ankara Bilkent City Hospital Medical Research Scientific and Ethical Evaluation Board (TABED). Written informed consent will be obtained from all participants, who may withdraw at any time without any effect on their care. The study will be conducted in accordance with the Declaration of Helsinki (2024 revision) and Good Clinical Practice, and personal data will be processed in line with the Turkish Personal Data Protection Law (KVKK, Law No. 6698).

03

Conditions studied

  • Fear of Childbirth
  • LABOR PAİN
  • Ceserean Section

Browse trials for

Keywords

  • Childbirth Fear
  • Tocophobia
  • Epidural Analgesia
  • Intrapartum Cesarean Delivery
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Nulliparous women aged 18 to 45 years with a singleton, cephalic, term pregnancy (37+0 to 41+6 weeks) who are admitted to the labor and delivery unit of Ankara Bilkent City Hospital, a tertiary referral center in Ankara, Türkiye, for planned vaginal birth, either in the latent phase of spontaneous labor or for induction of labor. Eligible women will be invited consecutively during the recruitment period.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Nulliparous women (no previous birth at 20 weeks of gestation or later)
  • Age 18 to 45 years
  • Singleton pregnancy in cephalic presentation
  • Term gestation of 37+0 to 41+6 weeks, dated by first-trimester ultrasound or a reliable last menstrual period
  • Admission to the labor and delivery unit for planned vaginal birth, either in the latent phase of spontaneous labor (cervical dilatation less than 5 cm) or for induction of labor
  • Able to read and understand Turkish
  • Written

Exclusion criteria

Exclusion Criteria:

  • Planned cesarean delivery or a to vaginal birth (for example placenta previa or previous uterine surgery entering the uterine cavity)
  • Cervical dilatation of 5 cm or more at enrollment
  • Any analgesic given for labor pain before the questionnaire is completed
  • Contraindication to neuraxial (epidural) analgesia, such as coagulopathy, significant thrombocytopenia or infection at the puncture site
  • Known major fetal anomaly or intrauterine fetal death
  • Severe maternal disease likely to change labor or analgesia management, such as preeclampsia with severe features or significant heart disease
  • Psychiatric disorder requiring medication, or current use of psychotropic drugs
  • Inability to complete the questionnaire, for example because of cognitive impairment or a language barrier
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Severe Fear of Childbirth (W-DEQ-A Score 85 or Higher)

    Nulliparous women with a term singleton pregnancy planning vaginal birth whose W-DEQ-A total score at enrollment is 85 or higher, indicating severe fear of childbirth. Participants receive routine labor care; no intervention is assigned by the investigators.

    Other: Wijma Delivery Expectancy/Experience Questionnaire, Version A (W-DEQ-A)

  • Non-severe Fear of Childbirth (W-DEQ-A Score Below 85)

    Nulliparous women with a term singleton pregnancy planning vaginal birth whose W-DEQ-A total score at enrollment is below 85. Participants receive routine labor care; no intervention is assigned by the investigators.

    Other: Wijma Delivery Expectancy/Experience Questionnaire, Version A (W-DEQ-A)

Interventions

  • OtherWijma Delivery Expectancy/Experience Questionnaire, Version A (W-DEQ-A)

    Self-administered Turkish version of the W-DEQ-A: 33 items rated on a 6-point Likert scale (total score 0-165; higher scores indicate greater fear of childbirth), completed once at enrollment before active labor and before any analgesia. It is used only to measure fear of childbirth and does not change clinical care.

06

What researchers measure

Primary outcomes

  1. Rate of Intrapartum (Unplanned) Cesarean Delivery

    Percentage of participants delivered by intrapartum (unplanned) cesarean section, compared between participants with a W-DEQ-A score of 85 or higher and those with a score below 85. The W-DEQ-A total score ranges from 0 to 165, with higher scores indicating greater fear of childbirth; the association with the continuous score will also be assessed.

    Time frame: From enrollment to delivery during the same hospital admission (up to 7 days)

Secondary outcomes

  1. Mode of Delivery

    Number and percentage of participants with spontaneous vaginal delivery, operative vaginal delivery (vacuum or forceps) and intrapartum cesarean delivery, compared between the two W-DEQ-A groups.

    Time frame: At delivery (up to 7 days after enrollment)

  2. Rate of Epidural Analgesia Request

    Percentage of participants who request epidural analgesia during labor, as documented by the attending midwife or physician, regardless of whether the epidural is placed.

    Time frame: From enrollment to delivery (up to 7 days)

  3. Cervical Dilatation at the Time of Epidural Request

    Cervical dilatation in centimeters (0-10 cm) at the vaginal examination performed at the time of the epidural request, among participants who request epidural analgesia. Lower values indicate an earlier request in labor.

    Time frame: At the time of epidural request (during labor)

  4. Labor Pain Intensity in Active Labor

    Pain intensity measured with a 10-cm visual analogue scale (VAS; 0 = no pain, 10 = worst imaginable pain; higher scores indicate more pain) at the first vaginal examination showing cervical dilatation of 5 cm or more, before any analgesia.

    Time frame: At the first vaginal examination showing cervical dilatation of 5 cm or more (active phase of labor)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • O'Connell MA, Leahy-Warren P, Khashan AS, Kenny LC, O'Neill SM. Worldwide prevalence of tocophobia in pregnant women: systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2017 Aug;96(8):907-920. doi: 10.1111/aogs.13138. Epub 2017 May 17. PubMed 28369672 ↗
  • Korukcu O, Kukulu K, Firat MZ. The reliability and validity of the Turkish version of the Wijma Delivery Expectancy/Experience Questionnaire (W-DEQ) with pregnant women. J Psychiatr Ment Health Nurs. 2012 Apr;19(3):193-202. doi: 10.1111/j.1365-2850.2011.01694.x. Epub 2012 Jan 20. PubMed 22260727 ↗
  • Wijma K, Wijma B, Zar M. Psychometric aspects of the W-DEQ; a new questionnaire for the measurement of fear of childbirth. J Psychosom Obstet Gynaecol. 1998 Jun;19(2):84-97. doi: 10.3109/01674829809048501. PubMed 9638601 ↗

Individual participant data

Plan to share: No — Individual participant data will not be shared, in accordance with the Turkish Personal Data Protection Law (KVKK, Law No. 6698), the informed consent obtained from participants and the institutional data-use commitment of Ankara Bilkent City Hospital. Aggregated results will be published in a peer-reviewed journal.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.

Of 31 non-industry observational studies under Labor Pain, half reached primary completion within 9 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 32. This study's planned 2 months is below that.

Counting every sponsor, half of 32 studies reached it within 9 months; a quarter within 6 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2026
First posted
Nov 18, 2026
StartActual
Oct 1, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Jan 31, 2027
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07944950
Responsible party
Ayşenur Türe (Specialist, Ankara City Hospital Bilkent) — Principal investigator
First posted
Nov 18, 2026
Start date
Oct 1, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Jan 31, 2027 (estimated)
Last update
Nov 18, 2026

Study contacts

AYŞENUR TÜRE, MD
Contact
draysenuryeniceri@gmail.com
+905377871445
AYŞENUR TÜRE
principal investigator · ANKARA BİLKENT CİTY HOSPİTAL

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion